RK
Ranjay Kumar Tripathi
About Ranjay Kumar Tripathi
Ranjay Kumar Tripathi has 11 years in corporate governance. Holds Director role. Currently with 3 companies, including Vyaprit Ventures Private Limited and Rvl Scientific & Engineering Private Limited. Formerly with 1 company, such as Aryak Drugs And Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Vyaprit Ventures Private Limited
U52609UP2021PTC148360
|
Director | 07 Jul 2021 | 2021 | Active |
Rvl Scientific & Engineering Private Limited
U74900UP2010PTC042082
|
Director | 08 Jul 2019 | 2010 | Active |
Ranvil Analyticals (Opc) Private Limited
U74999UP2018OPC105205
|
Director | 12 Jun 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Aryak Drugs And Pharma Private Limited
U24233DL2014PTC273267
|
Director | 17 Nov 2014 | 2014 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ranjay Kumar Tripathi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ranjay Kumar Tripathi
Ranjay Kumar Tripathi has 11 years in corporate governance. Holds Director role. Currently with 3 companies, including Vyaprit Ventures Private Limited and Rvl Scientific & Engineering Private Limited. Formerly with 1 company, such as Aryak Drugs And Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.
Ranjay Kumar Tripathi is associated with 3 companies as Director.
Ranjay Kumar Tripathi has expertise in General Business.
Ranjay Kumar Tripathi has 11 years in corporate governance.